The estimated Net Worth of Stuart Rich is at least $15.6 Millón dollars as of 11 June 2021. Dr Rich owns over 3,581,000 units of Tenax Therapeutics Inc stock worth over $15,616,143 and over the last 4 years he sold TENX stock worth over $0.
Sign up
Dr D TENX stock SEC Form 4 insiders trading
Dr has made over 1 trades of the Tenax Therapeutics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 3,581,000 units of TENX stock worth $13,178,080 on 11 June 2021.
The largest trade he's ever made was exercising 3,581,000 units of Tenax Therapeutics Inc stock on 11 June 2021 worth over $13,178,080. On average, Dr trades about 596,833 units every 0 days since 2021. As of 11 June 2021 he still owns at least 4,243,517 units of Tenax Therapeutics Inc stock.
You can see the complete history of Dr Rich stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Stuart Rich M.D. biography
Dr. Stuart Rich M.D. is the Chairman of Scientific Advisory Board, Chief Medical Officer & Director at Tenax Therapeutics Inc.
How old is Dr D?
Dr D is 71, he's been the Chairman of Scientific Advisory Board y Chief Medical Officer & Director of Tenax Therapeutics Inc since . There are 2 older and 13 younger executives at Tenax Therapeutics Inc. The oldest executive at Tenax Therapeutics Inc is Ronald Blanck, 75, who is the Independent Chairman of the Board.
What's Dr D's mailing address?
Stuart's mailing address filed with the SEC is 101 GLEN LENNOX DRIVE. SUITE 300, , CHAPEL HILL, NC, 27517.
Insiders trading at Tenax Therapeutics Inc
Over the last 10 years, insiders at Tenax Therapeutics Inc have traded over $5,051 worth of Tenax Therapeutics Inc stock and bought 571,282 units worth $853,236 . The most active insiders traders include Capital, Llc Armistice Capi..., Declan Doogan y Stuart Rich. On average, Tenax Therapeutics Inc executives and independent directors trade stock every 218 days with the average trade being worth of $1,664,103. The most recent stock trade was executed by Gerald T Proehl on 8 August 2024, trading 1,666 units of TENX stock currently worth $6,131.
What does Tenax Therapeutics Inc do?
tenax therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions. our development portfolio includes novel product candidates that have the potential to address various critical care conditions with high unmet medical need.
What does Tenax Therapeutics Inc's logo look like?
Complete history of Dr Rich stock trades at Tenax Therapeutics Inc
Tenax Therapeutics Inc executives and stock owners
Tenax Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Michael B. Jebsen CPA,
Advisor -
Anthony A. DiTonno,
CEO & Director -
Michael Jebsen,
President, Chief Financial Officer -
Michael B. Jebsen,
Pres & CFO -
Christopher T. Giordano,
CEO, Pres & Director -
Ellen Corliss,
Vice President, Corporate Communications & Investor Relations -
Chris Rallis,
Independent Director -
Gregory Pepin,
Independent Director -
Gerald Proehl,
Director -
James Mitchum,
Director -
Keith Maher,
Director -
Steven Boyd,
Director -
Paula Bokesch,
Chief Medical Officer -
Doug Randall,
Executive Vice President - Business and Commercial Operations -
Douglas Hay,
Executive Vice President - Regulatory Affairs -
Anthony DiTonno,
Chief Executive Officer, Director -
Ronald Blanck,
Independent Chairman of the Board -
Eliot M. Lurier CPA,
Interim Chief Financial Officer -
Dr. Stuart Rich M.D.,
Chairman of Scientific Advisory Board, Chief Medical Officer & Director -
Nancy J. M. Hecox,
Exec. VP of Legal Affairs, Gen. Counsel & Corp. Sec. -
John P Kelley,
Chief Executive Officer -
Michael H. Davidson,
-
Declan Doogan,
-
Stuart Rich,
Chief Medical Officer -
June Sherie Almenoff,
-
Robyn Hunter,
-
Christopher Thomas Giordano,
CEO